No Data
It's A Story Of Risk Vs Reward With Jinhe Biotechnology CO., LTD. (SZSE:002688)
Jinhe Biotechnology (002688.SZ): Recently, one invention patent certificate.
On March 18, Glonghui reported that Jinhe Biotechnology (002688.SZ) announced that it recently received an invention patent certificate issued by the National Intellectual Property Administration for the fermentation method, fermentation products, and applications of golden streptomyces fermentation yeast.
Jinhe Biotechnology (002688.SZ): Abandoning the priority right to acquire part of the minority shareholder equity of its controlled subsidiary Jinhe Pharmaceutical and increasing its capital.
On March 12, Gelonghui reported that Jinhe Biotechnology (002688.SZ) announced that the minority shareholders of its holding subsidiary Inner Mongolia Jinhe Pharmaceutical Technology Co., Ltd. (referred to as "Jinhe Pharmaceutical" or "symbol company"), including Lu Mudan, Li Fuzhong, and 11 others, plan to transfer all of their shares in Jinhe Pharmaceutical, along with part of the shares held by Zhang Hongyi, totaling 9.3 million yuan (accounting for 18.60%), to individuals Fang Jun, Xu Bing, and Guo Qilong. The company agreed to waive its right of first refusal on the partial transfer of shares in Jinhe Pharmaceutical under the same conditions. To further enhance the capital strength of Jinhe Pharmaceutical and support its business development, Jinhe Biotech...
Jinhe Biotechnology (002688.SZ): The product of aureofacient has preventive and therapeutic effects on specific animal diseases, but it does not directly target Bird Flu.
According to Gelonghui on March 6, Jinhe Biotechnology (002688.SZ) stated on the investor interaction platform that the company's Streptogramin products have preventive and therapeutic effects on certain animal diseases, but do not specifically target Bird Flu; the company is operating normally and all work is progressing smoothly.
Jinhe Biotechnology Gets Nod to Market Swine Pseudorabies Vaccine
The Five-year Loss for Jinhe Biotechnology (SZSE:002688) Shareholders Likely Driven by Its Shrinking Earnings
Some Jinhe Biotechnology CO., LTD. (SZSE:002688) Shareholders Look For Exit As Shares Take 27% Pounding